What is the difference between a CVR and an earn-out in terms of structuring, risk allocation, and accounting treatment?
A core M&A Advisory interview question — asked in analyst and associate interviews across IB, PE, and the Big 4.
THE SHORT ANSWER
A CVR is a tradable security that gives the holder a right to future payments contingent on specified events (e.g., drug approval), often used in pharma/biotech. An earn-out is a contractual provision in an SPA where additional consideration is paid based on future performance (e.g., revenue targets). CVRs are typically structured as standalone instruments, while earn-outs are part of the purchase price. Accounting: CVRs are classified as liabilities or equity; earn-outs are contingent consideration, remeasured at fair value through earnings each period.
WHAT INTERVIEWERS LISTEN FOR
- ✓CVR is tradable security; earn-out is contractual
- ✓CVR for binary events; earn-out for performance
- ✓CVR classified as liability/equity; earn-out as contingent consideration
- ✓Earn-out remeasured at fair value through P&L
COMMON MISTAKES
- ✗Treating CVR and earn-out as identical
- ✗Ignoring fair value remeasurement for earn-outs
Reading isn't the same as answering under pressure.
Interviewers don't hand you the model answer — you deliver yours on a clock. Practice this and 1,000+ questions with AI feedback on every answer.
RELATED QUESTIONS
- What is the difference between locked-box and completion-accounts pricing?
- When would you recommend an earn-out, and what are the risks?
- What is a reverse break fee (reverse termination fee)?
- What is staple(d) financing and why is it used?
- How do non-compete clauses work in German M&A?
- Explain the locked-box interest (equity ticker) mechanism.